CoChat

Clinical significance of CD 163+ tumor‐associated macrophages in patients with adult T‐cell leukemia/lymphoma

Open access
Komohara, Yoshihiro, Niino, Daisuke, Saito, Yoichi, Ohnishi, Koji, Horlad, Hasita, Ohshima, Koichi, Takeya, Motohiro · 2013 · Cancer Science
Cited by 113

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

Abstract

In several malignant tumors including lymphoma, macrophages that infiltrate tumor tissues are called tumor‐associated macrophages (TAM s). We discovered that TAM s, especially the CD 163+ alternatively activated phenotype (M2), were closely involved with progression of adult T‐cell leukemia/lymphoma (ATLL). We used CD 68 (a pan‐macrophage marker) and CD 163 (an M2 marker) to immunostain 58 ATLL samples. Statistical analyses showed that a high number of CD 68+ TAM s and an increased percentage of CD 163+ cells among the TAM s were associated with a worse clinical prognosis; multivariate analysis indicated that the percentage of CD 163+ cells was an independent prognostic factor. We also carried out in vitro coculture experiments with ATLL cell lines (ATN‐1 and TL‐Mor) and monocyte‐derived macrophages and found that direct coculture with M2 macrophages significantly increased BrdU incorporation into ATLL cell lines. A cytokine array analysis showed that macrophage‐derived soluble factors including C5a, tumor necrosis factor‐α, growth‐related oncogene‐α, CCL 1/I‐309, and interleukin‐6 stimulated ATLL cell lines. CD 163 expression in macrophages was strongly induced by direct contact with ATN‐1 cells, and downregulation of CD 163 in macrophages significantly suppressed growth of cocultured ATN‐1 cells. These results suggest that interaction between M2 macrophages and lymphoma cells may be an appropriate target in treatment of patients with ATLL.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cas.12167

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Cited by

See all 113

Metadata

Authors
Komohara, Y., Niino, D., Saito, Y., Ohnishi, K., Horlad, H., Ohshima, K., & Takeya, M.
Venue
Cancer Science
Publisher
Wiley
Published
2013-05-09
Volume
104
Issue
7
Pages
945-951
ISSN
  • 1347-9032 (ISSN-L)
  • 1349-7006
OpenAlex
W2040589111
Cited by
113
References
10
FWCI
4.72
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical significance of CD 163+ tumor‐associated macrophages in patients with adult T‐cell leukemia/lymphoma. https://app.cochat.ai/papers/10.1111/cas.12167
The paper
Komohara, Y., Niino, D., Saito, Y., Ohnishi, K., Horlad, H., Ohshima, K., & Takeya, M. (2013). Clinical significance of CD 163+ tumor‐associated macrophages in patients with adult T‐cell leukemia/lymphoma. Cancer Science. https://doi.org/10.1111/cas.12167

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.